multiple sclerosis

Biogen Seeking Deals to Expand Pipeline of MS Treatments
Bloomberg
Wed, 06/8/11 - 08:53 am
MS
multiple sclerosis
Biogen Idec
Biogen says European Union regulators approved once-a-week injection pen for MS
Yahoo/AP
Tue, 06/7/11 - 09:54 am
Biogen Idec
Europe
MS
multiple sclerosis
Avonex pen
Teva begins new double-dose Copaxone trial
Globes, Israel
Thu, 06/2/11 - 10:45 am
Teva Pharmaceuticals
Copaxone
MS
multiple sclerosis
Novartis’s Gilenya MS Drug Has 10,000 Users in U.S., Mundel Says
Bloomberg
Wed, 05/25/11 - 11:34 am
Novartis
MS
Gilenya
multiple sclerosis
CHMP Backs Biogen's Fampyra
Yahoo/Zacks.com
Tue, 05/24/11 - 08:28 am
Biogen Idec
Fampyra
CHMP
MS
multiple sclerosis
FDA: Tysabri risks greatest during year 3
Fierce Pharma
Tue, 04/26/11 - 06:21 am
FDA
Biogen Idec
Tysabri
MS
multiple sclerosis
XenoPort plans study on potential MS drug
Yahoo/AP
Mon, 04/25/11 - 11:17 am
MS
XenoPort
multiple sclerosis
arbaclofen placarbil
Biogen Idec's MS Drug Appears to Have an Edge
Motley Fool
Sat, 04/23/11 - 11:09 am
Biogen Idec
multiple sclerosis
BG-12
Gelenya
Novartis
Biogen surges on data for MS oral drug candidate
Yahoo/AP
Fri, 04/22/11 - 08:34 am
MS
multiple sclerosis
Biogen Idec
BG-12
Biogen’s 'Avonex Pen' wins tentative EU nod
Bizjournals.com
Tue, 04/19/11 - 11:18 am
Biogen Idec
Avonex
MS
multiple sclerosis
Europe
Avonex pen
EU Panel Recommends That Elan Update Tysabri MS Drug Label
Bloomberg
Mon, 04/18/11 - 10:59 am
Europe
Elan
MS
multiple sclerosis
Tysabri
Biogen Test Finds Tysabri Patients With 1% Risk of Getting Brain Disease
Bloomberg
Sat, 04/16/11 - 01:12 pm
Biogen Idec
Tysabri
progressive multifocal leukoencephalopathy
multiple sclerosis
Genzyme advances key drug in Sanofi deal
Bizjournals.com
Thu, 04/14/11 - 06:23 pm
Genzyme
Sanofi
MS
multiple sclerosis
alemtuzumab
Teva’s MS Pill Reduces Relapses Less Than Most Injected Drugs, Study Finds
Bloomberg
Tue, 04/12/11 - 09:24 am
Teva Pharmaceuticals
MS
multiple sclerosis
Copaxone
Biogen Idec MS drug meets goal in late-stage study
Yahoo/AP
Mon, 04/11/11 - 11:43 am
Biogen Idec
MS
BG-12
multiple sclerosis
Teva Announces Webcast on Results from Phase III ALLEGRO Study of Oral Laquinimod in Multiple Sclerosis
Pharmiweb
Sat, 04/9/11 - 11:48 am
Teva Pharmaceuticals
multiple sclerosis
Avanir Pharmaceuticals Announces Filing of IND for AVP-923 for the Treatment of Central Neuropathic Pain in Patients with Multiple Sclerosis
Yahoo
Mon, 04/4/11 - 11:37 am
neuropathic pain
MS
multiple sclerosis
AVP-923
Avanir
Novartis’s $48,000 Pill Spurs U.S. Price Increases for MS Drugs
Bloomberg
Tue, 03/22/11 - 11:07 am
Novartis
Gilenya
MS
multiple sclerosis
Teva Pharmaceuticals
Biogen Idec
Roche
Novartis gets EU approval for oral MS drug
Yahoo/AP
Mon, 03/21/11 - 11:19 am
Europe
MS
Novartis
multiple sclerosis
Teva Says Doctors Contacted on Trial of Generic Copaxone Drug
Bloomberg
Tue, 03/8/11 - 09:37 am
Teva Pharmaceuticals
generics
Copaxone
MS
multiple sclerosis

Pages